Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
2.55M
-
Shares change
-
+10.7K
-
Total reported value, excl. options
-
$256M
-
Value change
-
+$1.19M
-
Number of buys
-
39
-
Number of sells
-
-23
-
Price
-
$100.53
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q4 2022
82 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q4 2022.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.55M shares
of 3.2M outstanding shares and own 79.47% of the company stock.
Largest 10 shareholders include FMR LLC (382K shares), T. Rowe Price Investment Management, Inc. (342K shares), RENAISSANCE TECHNOLOGIES LLC (211K shares), BlackRock Inc. (206K shares), VANGUARD GROUP INC (168K shares), DIMENSIONAL FUND ADVISORS LP (153K shares), RICE HALL JAMES & ASSOCIATES, LLC (114K shares), HealthInvest Partners AB (94K shares), JPMORGAN CHASE & CO (83.2K shares), and Ranger Investment Management, L.P. (75.1K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.